CVRX News and Press, CVRx Inc. From 01/17/24

2024-01-17 22:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

MINNEAPOLIS, Jan. 11, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative extravascular implantable neuromodulation device for patients with ca...

2024-01-08 13:20:30 ET More on CVRx CVRx: Recent Good News Seems Fully Priced In Now CVRx, Inc. (CVRX) Q3 2023 Earnings Call Transcript CVRx sees better prospects for Barostim after FDA label update CVRx jumps as Medicare raises payment for heart implant ...

Fourth quarter revenue expected to be $11.2 million to $11.3 million, representing growth of 56% to 58% Full year revenue expected to be $39.2 million to $39.3 million, representing growth of 74% to 75% President and CEO Nadim Yared plans to retire upon the completion of a deliber...

2024-01-07 06:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-12-28 13:41:31 ET Summary Today, we look at CVRx, Inc., a medical device maker, which has seen its stock nearly triple over the past 10 weeks on positive news flow. Sales rose nearly 70% year-over-year in Q3 and the company got a positive billing change from the Centers for M...

MINNEAPOLIS, Dec. 27, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that the management ...

2023-12-26 08:54:24 ET More on CVRx CVRx, Inc. (CVRX) Q3 2023 Earnings Call Transcript CVRx jumps as Medicare raises payment for heart implant Seeking Alpha’s Quant Rating on CVRx Historical earnings data for CVRx Financial information for CVRx...

MINNEAPOLIS, Dec. 26, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc . (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the U.S. Food and Drug Administration (FDA) has approved revised Instructions For Use (IFU) for Barostim incorporating key long...

2023-12-01 06:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...